Company Profiles

driven by the PitchBook Platform

Acacia Pharma

Acacia Pharma
2006 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$23.5M LATEST DEAL AMOUNT
$34.7M TOTAL AMOUNT RAISED
Description

Developer of pharmaceutical products designed to offer cancer supportive care. The company's pharmaceutical products focuses on the development and commercialisation of new treatments, enabling patients with debilitating conditions arising as a consequence of surgery, cancer or cancer treatment get supportive care.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
Harston Mill
Harston
Cambridge CB22 7GG
England

+44 (0)12 2387 5130
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acacia Pharma’s full profile, request a free trial.

Acacia Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 03-Sep-2013 $23.5M $34.7M Completed Profitable
3. Later Stage VC 01-Feb-2012 00.000 000.00 Completed Profitable
2. Early Stage VC (Series A) 01-Apr-2011 $10.1M $10.1M $18.4M Completed Profitable
1. Early Stage VC 04-Mar-2008 Completed Profitable
To view this company’s complete deal history including valuation and funding request access »

Acacia Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.00 00.00 00 00.00 00.000
Series S 0,000,000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

Acacia Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
Gilde Healthcare Partners Venture Capital Minority 000 0000 000000 0
Lundbeckfond Ventures Venture Capital Minority 000 0000 000000 0
Novo Corporate Venture Capital Minority 000 0000 000000 0

You’re viewing 4 of 4 investors.

Acacia Pharma Executive Team (7)

Name Title Board
Seat
Contact
Info
Julian Gilbert Ph.D Chief Executive Officer, Board Member & Co-Founder
Scott Byrd Chief Operating Officer, Board Member & President
Christine Soden Chief Financial Officer, Company Secretary & Board Member
Robert Gristwood Chief Scientific Officer & Co-Founder
Ian Walker Ph.D Head of Project Leadership
You’re viewing 5 of 7 executives. Get the full list »

Acacia Pharma Board Members (8)

Name Representing Role Since Contact
Info
Alexander Pasteur Ph.D Self Board Member 000 0000
Carl Kordel Ph.D Lundbeckfond Ventures Board Member 000 0000
Christine Soden Acacia Pharma Chief Financial Officer, Company Secretary & Board Member 000 0000
Ian Kent Self Chairman 000 0000
Julian Gilbert Ph.D Acacia Pharma Chief Executive Officer, Board Member & Co-Founder 000 0000
You’re viewing 5 of 8 board members. Get the full list »